Page last updated: 2024-11-05

thalidomide and Dysplasia Linguofacialis

thalidomide has been researched along with Dysplasia Linguofacialis in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grosse, FR1
Wiedemann, H1
Jörgensen, G1

Reviews

2 reviews available for thalidomide and Dysplasia Linguofacialis

ArticleYear
Syndromes with reduction and surplus anomalies of the hand.
    Birth defects original article series, 1977, Volume: 13, Issue:1

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Fanconi Syndrome; Female; Fingers; Hand Deform

1977
[Human genetic aspects of inborn ear, nose, and throat diseases].
    HNO, 1985, Volume: 33, Issue:6

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Acrocephalosyndactylia; Child, Preschool; Chro

1985